Ross B. Fulton, Ph.D.
Affiliations: | 2010 | Microbiology | University of Iowa, Iowa City, IA |
Area:
Immunology, Microbiology Biology, Virology BiologyGoogle:
"Ross Fulton"Parents
Sign in to add mentor| Steven M. Varga | grad student | 2010 | University of Iowa | |
| (Regulation of virus-specific T cells in the lung during respiratory virus infections.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chan ASH, Kangas TO, Qiu X, et al. (2022) Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor Antibodies. Frontiers in Oncology. 12: 869078 |
| Truckenbrod EN, Burrack KS, Knutson TP, et al. (2021) CD8 T cell self-tolerance permits responsiveness but limits tissue damage. Elife. 10 |
| Raue A, Lu Y, Li O, et al. (2020) Abstract 2285: HFB10-1E1, a novel OX-40 agonistic antibody with a unique pharmacological profile and biomarker strategy Immunology. 80: 2285-2285 |
| Kamoun WS, Dugast AS, Suchy JJ, et al. (2019) Synergy between EphA2-ILs-DTXp, a novel EphA2 targeted nanoliposomal taxane, and PD-1 inhibitors in preclinical tumor models. Molecular Cancer Therapeutics |
| Tam EM, Fulton RB, Sampson JF, et al. (2019) Antibody-mediated targeting of TNFR2 activates CD8 T cells in mice and promotes antitumor immunity. Science Translational Medicine. 11 |
| Bose N, Ottoson NR, Qiu X, et al. (2019) Immune Pharmacodynamic Responses of the Novel Cancer Immunotherapeutic Imprime PGG in Healthy Volunteers. Journal of Immunology (Baltimore, Md. : 1950) |
| Sampson JF, Kurella VB, Paragas V, et al. (2019) Abstract 555: A novel human TNFR2 antibody (MM-401) modulates T cell responses in anti-cancer immunity Cancer Research. 79: 555-555 |
| Richards J, Wong C, Koshkaryev A, et al. (2019) Abstract 4846: MM-401, a novel anti-TNFR2 antibody that induces T cell co-stimulation, robust anti-tumor activity and immune memory Cancer Research. 79: 4846-4846 |
| Fulton RB, Camblin A, Sampson JF, et al. (2019) Abstract 3270: Mechanism of action of a novel agonist TNFR2 antibody that induces co-stimulation of T cells and promotes robust anti-tumor immunity Cancer Research. 79: 3270-3270 |
| Fraser KA, Kangas T, Fulton RB, et al. (2018) Abstract 3767: Imprime PGG, a soluble yeast b-glucan PAMP, enhancement of anti-tumor responses in combination with tumor targeting antibody is highly dependent on NK cell killing Immunology. 78: 3767-3767 |